Brief: Mithra Pharmaceuticals And Gedeon Richter Sign Binding Head Of Terms To Commercialize Estelle® And Donesta® In China

Mithra Pharmaceuticals SA

04/12/2023 06:12

Dec 4 (Reuters) - Mithra Pharmaceuticals SA  MITRA.BR :
    * MITHRA AND GEDEON RICHTER SIGN BINDING HEAD OF TERMS TO
COMMERCIALIZE ESTELLE® AND DONESTA® IN CHINA
    * MITHRA TO RECEIVE EUR 4.5 MILLION IN COMBINED MILESTONE
PAYMENTS
AT SIGNATURE OF LICENSE AGREEMENTS WITH ADDITIONAL COMBINED
REGULATORY MILESTONES OF EUR 1.2 MILLION
    * MITHRA ELIGIBLE TO RECEIVE A COMBINED TOTAL OF EUR 8.5
MILLION
SALES RELATED MILESTONES AND ADDITIONAL HIGH-SINGLE-DIGIT TO
LOW-DOUBLE-DIGIT PERCENT TIERED ROYALTIES AFTER LAUNCH
    * ESTELLE® TO TARGET AN ADDRESSABLE CONTRACEPTIVE MARKET IN
CHINA
VALUED AT EUR 104 MILLION ANNUALLY
    * DONESTA® TO TARGET AN ADDRESSABLE MENOPAUSE MARKET IN
CHINA
VALUED AT EUR 87 MILLION ANNUALLY

Source text for Eikon:  ID:nGNE31yyJn 
Further company coverage:  MITRA.BR 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))